Molecular Targeted Therapy for Biliary Tract Cancer- A Future Perspective
نویسنده
چکیده
Bile duct cancer is subdivided according to the anatomic location of origin into intrahepatic and extrahepatic cholangiocarcinoma, gallbladder cancer, or ampulla of Vater cancer. While biliary tract cancer is uncommon in Western countries, the incidence is relatively high in Asia, including Japan, and Latin America. However, in biliary tract cancers, the incidence of intrahepatic cholangiocarcinoma has been increasing even in the US, UK and Australia. In Japan, the estimated mortality of biliary tract cancer is 17,000 deaths annually.
منابع مشابه
New Horizons for Precision Medicine in Biliary Tract Cancers.
Biliary tract cancers (BTC), including cholangiocarcinoma and gallbladder cancer, are poor-prognosis and low-incidence cancers, although the incidence of intrahepatic cholangiocarcinoma is rising. A minority of patients present with resectable disease but relapse rates are high; benefit from adjuvant capecitabine chemotherapy has been demonstrated. Cisplatin/gemcitabine combination chemotherapy...
متن کاملCurrent status of chemotherapy for the treatment of advanced biliary tract cancer
Chemotherapy is indispensable for the treatment of advanced biliary tract cancer. Recently, reports regarding first-line chemotherapy have increased, and first-line chemotherapy treatment has become gradually more sophisticated. Gemcitabine and cisplatin combination therapy (or gemcitabine and oxaliplatin combination therapy) have become the standard of care for advanced biliary tract cancer. O...
متن کاملTargeted Therapy for Biliary Tract Cancer
It is necessary to establish effective chemotherapy to improve the survival of patients with biliary tract cancer, because most of these patients are unsuitable candidates for surgery, and even patients undergoing curative surgery often have recurrence. Recently, the combination of cisplatin plus gemcitabine was reported to show survival benefits over gemcitabine alone in randomized clinical tr...
متن کاملTargeted Therapy in Biliary Tract Cancers
OPINION STATEMENT A paradigm shift towards molecular-based, personalized cancer therapeutics has occurred in recent years and a number of targeted drugs have emerged. Various targeted therapies like erlotinib, trastuzumab, and cetuximab have been approved in lung, breast, and colon cancers, respectively. Numerous clinical trials involving targeted drugs in biliary tract cancers are currently in...
متن کاملCancer therapy related complications in the liver, pancreas, and biliary system: an imaging perspective
UNLABELLED Awareness of cancer therapy-induced toxicities is important for all clinicians treating patients with cancer. Cancer therapy has evolved to include classic cytotoxic agents in addition to newer options such as targeted agents and catheter-directed chemoembolisation. Several adverse affects can result from the wide array of treatments including effects on the liver, pancreas, and bili...
متن کامل